Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 5,000 shares at $6.38 ($32K) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Open-market purchase of $32k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |
| BCRX | SELL | 2021-10-19 | $1.6M | — | Filing → |